Cover Image
Market Research Report

Global Migraine Therapeutics Market 2018-2022

Published by TechNavio (Infiniti Research Ltd.) Product code 655621
Published Content info 102 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Migraine Therapeutics Market 2018-2022
Published: June 13, 2018 Content info: 102 Pages
Description

About migraine therapeutics

Migraine therapeutics caters to the treatment of acute or chronic migraine. It can be either preventive or abortive, that determines the treatment of migraine.

Technavio's analysts forecast the Global Migraine Therapeutics Market to grow at a CAGR of 5.38% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the migraine therapeutics market. To calculate the market size, the report considers the revenue generated from the sales of therapeutics such as migraine drugs and migraine devices.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Migraine Therapeutics Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Alder BioPharmaceuticals
  • Allergan
  • Amgen
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries

Market driver

  • Increasing number of patients suffering from migraine
  • For a full, detailed list, view our report

Market challenge

  • Side effects of migraine drugs
  • For a full, detailed list, view our report

Market trend

  • Growth in the number of migraine treatment awareness programs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents
Product Code: IRTNTR23203

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • Global migraine drugs market - Market size and forecast 2017-2022
  • Global migraine devices market - Market size and forecast 2017-2022
  • Market opportunity by product

PART 08: MARKET SEGMENTATION BY TREATMENT

  • Preventive treatment
  • Abortive treatment

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Growth in the number of migraine treatment awareness programs
  • Increase in the availability of late-stage pipeline products
  • Rise in the popularity of devices for migraine treatment

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Alder BioPharmaceuticals
  • Allergan
  • Amgen
  • Eli Lilly and Company
  • Teva Pharmaceutical Industries

PART 16: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global CNS therapeutics market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global migraine therapeutics market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global migraine therapeutics market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global migraine therapeutics market by product - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global migraine drugs market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global migraine drugs market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global migraine devices market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global migraine devices market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Market opportunity by product
  • Exhibit 25: Customer landscape
  • Exhibit 26: Global migraine therapeutics market by geography - Market share 2017-2022 (%)
  • Exhibit 27: Regional comparison
  • Exhibit 28: Migraine therapeutics market in the Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 29: Migraine therapeutics market in the Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 30: Migraine therapeutics market in EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Migraine therapeutics market in EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: Migraine therapeutics market in APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Migraine therapeutics market in APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 34: Key leading countries
  • Exhibit 35: Market opportunity
  • Exhibit 36: Vendor landscape
  • Exhibit 37: Landscape disruption
  • Exhibit 38: Vendors covered
  • Exhibit 39: Vendor classification
  • Exhibit 40: Market positioning of vendors
  • Exhibit 41: Alder BioPharmaceuticals: Overview
  • Exhibit 42: Alder BioPharmaceuticals - Business segments
  • Exhibit 43: Alder BioPharmaceuticals - Organizational developments
  • Exhibit 44: Alder BioPharmaceuticals - Key offerings
  • Exhibit 46: Allergan: Overview
  • Exhibit 47: Allergan - Business segments
  • Exhibit 48: Allergan - Organizational developments
  • Exhibit 49: Allergan - Segment focus
  • Exhibit 50: Allergan - Key offerings
  • Exhibit 51: Allergan - Key customers
  • Exhibit 52: Amgen: Overview
  • Exhibit 53: Amgen - Business segments
  • Exhibit 54: Amgen - Organizational developments
  • Exhibit 55: Amgen - Geographic focus
  • Exhibit 56: Amgen - Key offerings
  • Exhibit 57: Eli Lilly and Company: Overview
  • Exhibit 58: Eli Lilly and Company - Business segments
  • Exhibit 59: Eli Lilly and Company - Organizational developments
  • Exhibit 60: Eli Lilly and Company - Geographic focus
  • Exhibit 61: Eli Lilly and Company - Segment focus
  • Exhibit 62: Eli Lilly and Company - Key offerings
  • Exhibit 63: Teva Pharmaceutical Industries: Overview
  • Exhibit 64: Teva Pharmaceutical Industries - Business segments
  • Exhibit 65: Teva Pharmaceutical Industries - Organizational developments
  • Exhibit 66: Teva Pharmaceutical Industries - Geographic focus
  • Exhibit 67: Teva Pharmaceutical Industries - Segment focus
  • Exhibit 68: Teva Pharmaceutical Industries - Key offerings
Back to Top